Differential neurotoxicity induced by L-DOPA and dopamine in cultured striatal neurons (Q34415141)

2 August 2017

title

Differential neurotoxicity induced by L-DOPA and dopamine in cultured striatal neurons (English)

1 reference

2 August 2017

0 references

1 reference

1 reference

1 reference

T Maeda

2

0 references

author name string

N Cheng

1

1 reference

2 August 2017

T Kume

3

1 reference

2 August 2017

S Kaneko

4

1 reference

2 August 2017

H Kochiyama

5

1 reference

2 August 2017

A Akaike

6

1 reference

2 August 2017

Y Goshima

7

1 reference

2 August 2017

Y Misu

8

1 reference

2 August 2017

language of work or name

English

0 references

publication date

1 December 1996

1 reference

2 August 2017

number of pages

6

1 reference

based on heuristic

inferred from page(s)

published in

Brain Research

1 reference

2 August 2017

volume

743

1 reference

2 August 2017

issue

1-2

1 reference

2 August 2017

page(s)

278-283

1 reference

Changes in extracellular levels of glutamate and aspartate in rat substantia nigra induced by dopamine receptor ligands: in vivo microdialysis studies

2 August 2017

cites work

1 reference

https://api.crossref.org/works/10.1016%2FS0006-8993%2896%2901056-6

Cholecystokinin-induced protection of cultured cortical neurons against glutamate neurotoxicity

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0006-8993%2896%2901056-6

Dopamine-induced protection of striatal neurons against kainate receptor-mediated glutamate cytotoxicity in vitro

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0006-8993%2896%2901056-6

L-dopa cytotoxicity to PC12 cells in culture is via its autoxidation.

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0006-8993%2896%2901056-6

Dopamine Neurotoxicity: Inhibition of Mitochondrial Respiration

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0006-8993%2896%2901056-6

Does levodopa aggravate Parkinson's disease?

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0006-8993%2896%2901056-6

Inhibitory effects of noradrenaline and dopamine on calcium influx and neurotransmitter glutamate release in mammalian brain slices

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0006-8993%2896%2901056-6

Basal lipid peroxidation in substantia nigra is increased in Parkinson's disease

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0006-8993%2896%2901056-6

Effect of ischemia on the in vivo release of striatal dopamine, glutamate, and gamma-aminobutyric acid studied by intracerebral microdialysis

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0006-8993%2896%2901056-6

L-dopa induces Ca(2+)-dependent and tetrodotoxin-sensitive release of endogenous glutamate from rat striatal slices

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0006-8993%2896%2901056-6

Developmental regulation of mRNAs encoding rat brain kainate/AMPA receptors: a northern analysis study

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0006-8993%2896%2901056-6

Ascorbate neurotoxicity in cortical cell culture

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0006-8993%2896%2901056-6

Levodopa toxicity in foetal rat midbrain neurones in culture: modulation by ascorbic acid.

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0006-8993%2896%2901056-6

Central catecholamine neuron systems: anatomy and physiology of the dopamine systems

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0006-8993%2896%2901056-6

Toxic and protective effects of L-dopa on mesencephalic cell cultures

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0006-8993%2896%2901056-6

Excitotoxicity of L-dopa and 6-OH-dopa: implications for Parkinson's and Huntington's diseases

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0006-8993%2896%2901056-6

Parkinson's disease: a disorder due to nigral glutathione deficiency?

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0006-8993%2896%2901056-6

Dopamine--glutamate--GABA interactions and ageing: studies in the striatum of the conscious rat

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0006-8993%2896%2901056-6

Oxidants in mitochondria: from physiology to diseases

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0006-8993%2896%2901056-6

Transition Metals, Ferritin, Glutathione, and Ascorbic Acid in Parkinsonian Brains

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0006-8993%2896%2901056-6

Plasma levodopa, dopamine and therapeutic response following levodopa therapy of Parkinsonian patients

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0006-8993%2896%2901056-6

Role for excitatory amino acids in methamphetamine-induced nigrostriatal dopaminergic toxicity.

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0006-8993%2896%2901056-6

Protection of substantia nigra from MPP+ neurotoxicity by N-methyl-D-aspartate antagonists

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0006-8993%2896%2901056-6

L-dopa increases nigral production of hydroxyl radicals in vivo: potential L-dopa toxicity?

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0006-8993%2896%2901056-6

inferred from DOI database lookup

7 January 2021

based on heuristic

Identifiers

DOI

10.1016/S0006-8993(96)01056-6

1 reference

2 August 2017

1 reference